Harold S. Nelson

Harold S. Nelson's AcademicInfluence.com Rankings

Harold S. Nelson

Medical

#1874

World Rank

#2255

Historical Rank

Pharmacology

#180

World Rank

#219

Historical Rank

medical Degrees

Harold S. Nelson

Philosophy

#5547

World Rank

#8378

Historical Rank

Logic

#2804

World Rank

#3850

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Harold S. Nelson's Degrees

PhD Pharmacology University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Harold S. Nelson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Harold S. Nelson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. (2006) (1146)
Allergen immunotherapy: a practice parameter third update. (2007) (1005)
Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. (1997) (552)
Sublingual immunotherapy: World Allergy Organization position paper 2013 update (2014) (496)
Treatment of peanut allergy with rush immunotherapy. (1992) (461)
Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. (1999) (454)
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. (2013) (446)
Sub‐lingual Immunotherapy: World Allergy Organization Position Paper 2009 (2009) (435)
Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. (2001) (432)
Sublingual immunotherapy: a comprehensive review. (2006) (373)
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) (351)
The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group. (1999) (339)
Onset and persistence of childhood asthma: predictors from infancy. (2001) (310)
Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. (1993) (289)
Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. (2006) (241)
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. (2000) (231)
Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. (1998) (207)
β-Adrenergic Bronchodilators (1995) (204)
Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults. (2011) (200)
Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. (2012) (196)
Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma. (2010) (185)
The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program. (1999) (173)
Quantitative IgE antibody assays in allergic diseases. (2000) (167)
Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics. (1979) (162)
Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. (2003) (161)
Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial. (2008) (151)
Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial (2010) (144)
Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract. (2009) (142)
Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma. (1999) (142)
Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies. (2000) (136)
The effect of theophylline on the lower esophageal sphincter pressure. (1980) (135)
A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. (1993) (129)
Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber. (2015) (128)
An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. (2013) (128)
Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. (2004) (126)
Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. (2000) (125)
Sub-Lingual Immunotherapy (2009) (124)
A comparison of commercial jet nebulizers. (1994) (123)
Effectiveness of specific immunotherapy in the treatment of asthma: a meta-analysis of prospective, randomized, double-blind, placebo-controlled studies. (2000) (122)
Potential adverse effects of the inhaled corticosteroids. (2003) (121)
Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. (2010) (120)
Studies of allergen extract stability: the effects of dilution and mixing. (1996) (119)
An approach to the patient with a history of local anesthetic hypersensitivity: experience with 90 patients. (1979) (119)
Advances in upper airway diseases and allergen immunotherapy. (2003) (118)
Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial. (2014) (115)
Meta-analysis: Effects of Adding Salmeterol to Inhaled Corticosteroids on Serious Asthma-Related Events (2008) (113)
The importance of allergens in the development of asthma and the persistence of symptoms. (2001) (112)
Subsensitivity to the bronchodilator action of albuterol produced by chronic administration. (1977) (109)
Aerosolized terbutaline in asthmatics: development of subsensitivity with long-term administration. (1982) (105)
The role of the peak flow meter in the diagnosis and management of asthma. (1991) (105)
Evaluation of devices for skin prick testing. (1998) (104)
Comparative performance of five commercial prick skin test devices. (1993) (104)
An assessment of the role of intradermal skin testing in the diagnosis of clinically relevant allergy to timothy grass. (1996) (102)
Allergen immunotherapy: where is it now? (2007) (99)
Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial. (2016) (99)
The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels. (1978) (98)
Multiallergen immunotherapy for allergic rhinitis and asthma. (2009) (98)
A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract. (2003) (97)
Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. (2005) (97)
Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database (2010) (95)
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler. (1999) (94)
Effectiveness of specific immunotherapy in the treatment of hymenoptera venom hypersensitivity: a meta-analysis. (2000) (94)
Effect of distance between sites and region of the body on results of skin prick tests. (1996) (88)
A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids. (1993) (88)
Cross-allergenicity among the grasses. (1985) (85)
Skin testing: a survey of allergists. (2006) (84)
Recommendations for appropriate sublingual immunotherapy clinical trials. (2009) (83)
Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma. (2001) (79)
Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate-Theophylline Study Group. (1998) (78)
Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy. (2015) (78)
Comparison of PEFR and FEV1 in patients with varying degrees of airway obstruction. Effect of modest altitude. (1989) (78)
Recommendations for the use of residential air-cleaning devices in the treatment of allergic respiratory diseases. (1988) (77)
Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma. (1999) (77)
Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells. (1997) (76)
An evaluation of the pharmacologic inhibition of the immediate and late cutaneous reaction to allergen (1980) (75)
Aerosolized terbutaline in asthmatics. Comparison of dosage strength, schedule, and method of administration. (1979) (74)
Effect of preservatives and conditions of storage on the potency of allergy extracts. (1981) (74)
Efficacy and safety of the SQ‐standardized grass allergy immunotherapy tablet in mono‐ and polysensitized subjects (2013) (74)
Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma. (1999) (74)
Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. (2001) (71)
Chronic urticaria exacerbated by the antioxidant food preservatives, butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT). (1990) (69)
Pollen allergens and their interrelationships (1985) (67)
The use of standardized extracts in allergen immunotherapy. (2000) (67)
Safety and efficacy of oral immunotherapy with standardized cat extract. (1994) (66)
Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective? (2014) (66)
A comparison of six epicutaneous devices in the performance of immediate hypersensitivity skin testing. (1989) (65)
Gastroesophageal reflux and pulmonary disease. (1984) (64)
Is there a problem with inhaled long-acting β-adrenergic agonists? (2006) (64)
Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone. (2001) (64)
Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data. (2004) (62)
Skin test suppression by antihistamines and the development of subsensitivity. (1985) (62)
Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis. (1997) (61)
Prospects for antihistamines in the treatment of asthma. (2003) (61)
Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome. (2013) (61)
Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses. (2016) (60)
Immediate skin test reactivity to Food and Drug Administration-approved standardized extracts. (1990) (60)
Adrenergic therapy of bronchial asthma. (1986) (57)
Immunologic response to administration of standardized dog allergen extract at differing doses. (2006) (56)
Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure (2014) (56)
Theophylline and aerosolized terbutaline in the treatment of bronchial asthma. Double-blind comparison of optimal doses. (1980) (56)
Recent advances in allergic rhinitis (2018) (55)
Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report (2013) (55)
Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group. (1998) (54)
Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers. (2004) (52)
Hydrofluoroalkane-134A Beclomethasone or Chlorofluorocarbon Fluticasone: Effect on Small Airways in Poorly Controlled Asthma (2005) (52)
Delayed hypersensitivity in cancer patients: cutaneous and in vitro lymphocyte response to specific antigens. (1969) (51)
The bronchodilator response to inhalation of increasing doses of aerosolized albuterol. (1983) (51)
Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients. (2008) (49)
Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma. (1999) (47)
Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. (2001) (47)
One-year treatment with mometasone furoate in chronic obstructive pulmonary disease (2008) (46)
Safety of formoterol in patients with asthma: combined analysis of data from double-blind, randomized controlled trials. (2010) (45)
Regular inhaled beta-adrenergic agonists in the treatment of bronchial asthma: beneficial or detrimental? (1991) (44)
Beta adrenergic agonists. (1982) (44)
Nasal immunotherapy in weed-induced allergic rhinitis. (1997) (43)
Subsensitivity to epinephrine following the administration of epinephrine and ephedrine to normal individuals. (1975) (42)
The effect of preservatives and dilution on the deterioration of Russian thistle (Salsola pestifer), a pollen extract. (1979) (42)
Recruitment of participants in the childhood Asthma Management Program (CAMP). I. Description of methods: Childhood Asthma Management Program Research Group. (1999) (42)
Optimal duration of nebulized albuterol therapy. (1993) (39)
Alternative agents for anti-inflammatory treatment of asthma. (1998) (39)
Extreme variability in aerosol output of the DeVilbiss 646 jet nebulizer. (1991) (38)
Advances in upper airway diseases and allergen immunotherapy. (2004) (37)
Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated. (2016) (37)
A laboratory evaluation of immune complexes in patients on inhalant immunotherapy. (1978) (36)
Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study. (2007) (35)
Skin testing. (2006) (35)
Characterization of Chenopodiales (Amaranthus retroflexus, Chenopodium album, Kochia scoparia, Salsola pestifer) pollen allergens (1995) (34)
Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines. (2002) (34)
Clinically important differences in health-related quality of life for patients with asthma: an expert consensus panel report. (2003) (33)
Seasonal variation in immediate skin test reactions. (1993) (33)
Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids. (2001) (33)
Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trial. (2007) (33)
Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets. (2017) (33)
Efficacy and safety of fluticasone propionate 44 μg/salmeterol 21 μg administeredin a hydrofluoroalkane metered-dose inhaleras an initial asthma maintenance treatment (2003) (33)
Clinical experience with levalbuterol. (1999) (32)
Advances in upper airway diseases and allergen immunotherapy. (2004) (32)
The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma (2008) (31)
Specific immunotherapy with allergen mixes: what is the evidence? (2009) (31)
An examination of food hypersensitivity as a cause of increased bronchial responsiveness to inhaled methacholine. (1991) (31)
Comparative efficacy and safety of albuterol sulfate Spiros inhaler and albuterol metered-dose inhaler in asthma. (1999) (30)
Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe. (2016) (29)
Addition of terbutaline to optimal theophylline therapy. Double blind crossover study in asthmatic patients. (1986) (28)
Variables in allergy skin testing. (1994) (27)
Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis. (2006) (27)
Characterization of aerosol output from various nebulizer/compressor combinations. (2001) (27)
Patient and physician perspectives on the attributes of nasal allergy medications. (2007) (27)
Evaluation of combined H1- and H2-receptor blocking agents in the treatment of seasonal allergic rhinitis. (1983) (25)
Analysis of meteorologic variables and seasonal aeroallergen pollen counts in Denver, Colorado. (1995) (25)
Prevalence of house dust mites in the Rocky Mountain states. (1995) (25)
Circadian variation of skin reactivity and allergy skin tests. (1989) (25)
A comparison of multiheaded devices for allergy skin testing. (2004) (25)
Beta-adrenergic bronchodilators. (1995) (25)
Allergen immunotherapy now and in the future. (2016) (25)
Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial. (2016) (24)
Lack of correlation between Chlamydia pneumoniae antibody titers and adult-onset asthma. (2000) (24)
Long-acting beta-agonists in adult asthma: Evidence that these drugs are safe. (2006) (24)
Greater inhibition of dermographia with a combination of H1 and H2 antagonists. (1983) (24)
Cromolyn sodium in seasonal allergic conjunctivitis. (1985) (24)
Current reviews of allergy and clinical immunology (2005) (24)
Vocal cord dysfunction with nocturnal awakening. (1997) (23)
Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial (2015) (23)
Suppression of immediate skin tests by ranitidine. (1989) (23)
Experience with daily immunotherapy in 59 adult allergic patients. (1982) (23)
Update on house dust mite immunotherapy: are more studies needed? (2014) (22)
The development of subsensitivity to chlorpheniramine. (1985) (22)
Current issues relating to in vitro testing for allergen-specific IgE: a workshop report. (1999) (22)
Diagnostic procedures in allergy. I. Allergy skin testing. (1983) (22)
Is there a problem with inhaled long-acting beta-adrenergic agonists? (2006) (21)
Inhalation devices, delivery systems, and patient technique. (2016) (21)
The effect of ephedrine on the response to epinephrine in normal men. (1973) (21)
Suggested approaches for research protocols involving the potential for life-threatening reactions. (1993) (21)
Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma (2012) (21)
Immunotherapy for Inhalant Allergens (2009) (21)
Subcutaneous injection immunotherapy for optimal effectiveness. (2011) (21)
How ill the wind? Issues in aeroallergen sampling. (2003) (20)
Safety of Long-Acting -Agonists (2006) (20)
A Comparison of Methods for Assessing Hypothalamic‐Pituitary‐Adrenal (HPA) Axis Activity in Asthma Patients Treated with Inhaled Corticosteroids (2002) (20)
Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ Workshop. (2019) (19)
Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma. (2004) (17)
Mechanisms of intranasal steroids in the management of upper respiratory allergic diseases. (1999) (17)
Efficacy and safety of allergen immunotherapy in children. (2006) (17)
Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment. (2003) (17)
Cross allergenicity among grasses determined by tissue threshold changes. (1985) (16)
Use of standardized and conventional allergen extracts in prick skin testing. (1992) (16)
Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents (2017) (16)
Budesonide Turbuhaler delivered once daily improves health-related quality of life and maintains improvements with a stepped-down dose in adults with mild to moderate asthma. (2003) (16)
Measurement of changes in mRNA for IL-5 in noninvasive scrapings of nasal epithelium taken from patients undergoing nasal allergen challenge. (2002) (16)
The effect of corticosteroids on theophylline metabolism. (1983) (16)
Fluticasone propionate results in improved glucocorticoid receptor binding affinity and reduced oral glucocorticoid requirements in severe asthma. (1998) (16)
Efficacy of atropine methylnitrate alone and in combination with albuterol in children with asthma. (1990) (16)
Effect of RG 12525, a new leukotriene antagonist, on pulmonary function of asthmatic adults. (1994) (16)
SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis. (2016) (15)
Dermographia caused by IgE mediated penicillin allergy. (1983) (15)
Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA (2014) (15)
A possible role for cyclooxygenase 2 inhibitors in the treatment of chronic urticaria. (2003) (15)
Variables in Allergy Skin Testing (2001) (15)
Double-blind trial of pyridoxine (vitamin B6) in the treatment of steroid-dependent asthma. (1993) (15)
Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles (2017) (15)
Combination therapy of long-acting β agonists and inhaled corticosteroids in the management of chronic asthma (2005) (15)
Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial. (2020) (15)
Failure of colchicine to reduce inhaled triamcinolone dose in patients with asthma. (1997) (14)
Safety of long-acting β-agonists in asthma: a review (2008) (14)
The effect of ascorbic acid on cutaneous and nasal response to histamine and allergen. (1982) (14)
The Beta Adrenergic Theory of bronchial asthma. (1975) (14)
Aerobiology of the Colorado Rockies: pollen count comparisons between Vail and Denver, Colorado. (1992) (13)
Tissue threshold changes during the first months of immunotherapy. (1980) (13)
Daclizumab improves asthma control in patients with refractory asthma (2005) (13)
Effect of the inhaled corticosteroid mometasone on small airway patency in patients with asthma. (2009) (13)
Update on the safety of long-acting beta-agonists in combination with inhaled corticosteroids for the treatment of asthma. (2009) (12)
Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet (2012) (12)
β-Adrenercic Subsensitivity Induced by Chronic Administration of Terbutaline (1977) (12)
Workshop 5: Assessment of efficacy (1986) (12)
A double-blind evaluation of skin test suppression produced by two doses of terfenadine. (1987) (12)
Comparison of the bronchodilator response to albuterol administered by the OptiHaler, the AeroChamber, or by metered dose inhaler alone. (1994) (12)
Delivery of glucocorticoids by jet nebulization: aerosol characteristics and output. (1995) (12)
145. Cross-reactivity among weeds of the Amaranth and Chenopod families (1978) (11)
Controlled trials with four per cent cromolyn spray in seasonal allergic rhinitis * (1977) (11)
THE ROLE OF ALLERGY (1999) (11)
Comparison of three commercial ultrasonic nebulizers. (2000) (11)
Short ragweeds is highly cross-reactive with other ragweeds. (2015) (11)
Efficacy/safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial (2010) (10)
Recommendations for the pharmacologic management of allergic rhinitis. (2014) (10)
A prospective assessment of the remote practice of allergy: comparison of the diagnosis of allergic disease and the recommendations for allergen immunotherapy by board-certified allergists and a laboratory performing in vitro assays. (1993) (10)
Is sublingual immunotherapy ready for use in the United States? (2013) (10)
New forms of allergy immunotherapy for rhinitis and asthma. (2014) (10)
Comparing conventional and acetone-precipitated dog allergen extract skin testing. (2001) (9)
Single Isomer Versus Racemate: Is There a Difference? Clinical Comparisons in Allergy and Gastroenterology (2002) (9)
Arg16Gly Polymorphism of the β2-adrenergic Receptor Gene Does Not Modulate Clinical Response to Salmeterol in Subjects with Asthma (2008) (9)
Suppression of the skin reaction to histamine by ebastine. (1995) (9)
Advances in upper airway diseases and allergen immunotherapy. (2006) (9)
Does allergen immunotherapy have a role in the treatment of bronchial asthma? (1997) (9)
Long-Term Safety of a Non-Chlorofluorocarbon- Containing Triamcinolone Acetonide Inhalation Aerosol in Patients with Asthma (2000) (9)
Preparing and mixing allergen vaccines for subcutaneous immunotherapy. (2008) (9)
Preparing and mixing allergen vaccines. (2004) (9)
Efficacy and Safety of the SQ-House Dust Mite Sublingual Immunotherapy Tablet in North American Children and Adults: Findings from a Large Randomized, Placebo-Controlled Clinical Trial (2016) (9)
Allergy immunotherapy: Future directions for the 2020s. (2020) (9)
Long-acting inhaled beta agonists. (1995) (9)
Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis (2014) (9)
Double-blind trial of a heated nasal aerosol in the treatment of perennial allergic rhinitis. (1993) (9)
Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report. (2020) (9)
House dust mites in Colorado. (1985) (8)
Allergen Immunotherapy: A Centenary Celebration (2011) (8)
Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy Tablet. (2018) (8)
Effect of beta-adrenergic agents on immunoglobulin G levels of asthmatic subjects. (1982) (8)
Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma (2017) (8)
A random double-blind trial of the combination of nebulized atropine methylnitrate and albuterol in nocturnal asthma. (1990) (8)
Short-term safety of somatropin inhalation powder in adults with mild to moderate asthma. (2009) (8)
Allergen and irritant control: importance and implementation. (1998) (8)
The effect of cimetidine on the immediate cutaneous response to allergens. (1979) (7)
Long-Term Safety of Flunisolide Hydrofluoroalkane Metered-Dose Inhaler in Adults and Adolescents with Asthma (2001) (7)
Pirbuterol Hydrochloride: Evaluation of Beta Adrenergic Agonist Activity in Reversible Obstructive Pulmonary Disease and Congestive Heart Failure (1984) (7)
Sublingual immunotherapy: the U.S. experience (2013) (6)
DIFFERENTIAL DIAGNOSISOF ADULT ASTHMA (1996) (6)
Assessment of IgE-mediated sensitivity during immunotherapy: comparison of the RAST with and without adsorption of IgG to titrated prick skin tests. (1986) (6)
Effects of Combined Treatment with Cat Allergen Immunotherapy and Tezepelumab on Nasal Allergen Challenge (2020) (6)
Allergen immunotherapy: what’s new, what’s next? (2015) (6)
The effect of positive and negative air ions on bronchial asthma. (1983) (6)
19 – In Vivo Testing for Immunoglobulin E-Mediated Sensitivity (2016) (6)
Mediator measurements after daily instillation of allergen: Increased IL-5 and decreased IFN-gamma. (2008) (6)
Combination therapy of bronchial asthma. (2001) (6)
Are meta-analysis-based comparisons solid evidence? (2013) (5)
Allergy immunotherapy for inhalant allergens: Strategies to improve efficacy. (2020) (5)
Immunotherapy for house-dust mite allergy. (2018) (5)
Long-term immunotherapy with aqueous and aluminum-precipitated grass extracts. (1980) (5)
An investigation of possible immunologic reactions to human serum albumin used as a stabilizer in allergy extracts. (1985) (5)
Comparison of parallel line skin test assay (PLST) and ELISA inhibition (EI) methods for determination of relative potency of polymerized grass and ragweed antigenic extracts. (1988) (5)
What is atopy? Sidestepping semantics. (1984) (5)
The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children (2014) (5)
Chronic chlorpheniramine therapy: subsensitivity, drug metabolism, and compliance. (1987) (4)
Clinical aspects of allergic disease Evaluation of devices for skin prick testing (1998) (4)
Allergen Immunotherapy for a Teenager with Seasonal Allergic Rhinitis Due to Grass Pollen: Subcutaneous or Sublingual Route? (2017) (4)
The Evolution of Allergy Immunotherapy. (2020) (4)
2020 Updated Asthma Guidelines: Allergen immunotherapy. (2020) (4)
Advances in upper airway diseases and allergen immunotherapy. (2003) (4)
Long-term safety of a non-chlorofluorocarbon-containing triamcinolone acetonide inhalation aerosol in patients with asthma. Azmacort HFA Study Group. (2000) (4)
Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient (2016) (4)
Analyzing asthma phenotypes (2004) (4)
Current standards and future directions in immunotherapy: perspectives on challenges and opportunities for the allergist. (2011) (4)
Current and future challenges of subcutaneous and sublingual allergy immunotherapy for allergists in the United States. (2018) (4)
The effects of weekly versus monthly ragweed allergen injections on immunological parameters. (1981) (4)
Lability of blocking antibody during ragweed immunotherapy. (1983) (4)
Optimization of intranasal corticosteroid formulations for the treatment of allergic rhinitis. (2007) (4)
The Bela Schick lecture for 1985. The atopic diseases. (1985) (4)
Allergy immunotherapy for inhalant allergens: Strategies to minimize adverse reactions. (2020) (4)
Some highlights of the first century of immunotherapy. (2011) (4)
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: a randomized controlled trial. (2022) (3)
Relation between positive small air ions, weather fronts and pulmonary function in patients with bronchial asthma. (1983) (3)
Ozone upregulates nasal epidermal growth factor receptors (2004) (3)
Jack Pepys' contributions to the medical literature. (2009) (3)
Anti–IL-5 for hypereosinophilia (2004) (3)
Ragweed allergy immunotherapy tablet MK-3641 (Ragwitek®) for the treatment of allergic rhinitis (2018) (3)
The effect of theophylline and enprofylline on the late cutaneous response to antigen and compound 48/80. (1989) (3)
The development of subsensitivity to atropine methylnitrate. A double-blind, placebo-controlled crossover study. (1988) (3)
In patients taking fluticasone propionate/salmeterol 100/50μg Diskus ® for asthma, fluticasone propionate nasal spray 200μg QD is superior to montelukast 10mg QD in the treatment of allergic rhinitis in patients with coexistent allergic rhinitis (2004) (3)
Future directions in allergen immunotherapy. (2022) (3)
Characterization of Asthma Exacerbations by Arg16Gly Genotype in Subjects with Asthma Receiving Salmeterol Alone or with Fluticasone Propionate (2008) (3)
NEW ONSET ASTHMA IN THE ELDERLY (1997) (3)
Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets for Treatment of Allergic Rhinitis with/without Conjunctivitis (2015) (3)
Evaluation of a skin test device designed to be less painful. (2012) (3)
Quality assurance in allergy skin testing. (1993) (3)
Frequent parenteral terbutaline in the treatment of status asthmaticus in children. (1987) (3)
Drug allergy. Best diagnostic and treatment approaches. (1990) (3)
The effect of troleandomycin and methylprednisolone alone and in combination on bronchial sensitivity to methacholine. (1983) (3)
beta-Adrenergic subsensitivity induced by chronic administration of terbutaline. (1977) (3)
Dose-Finding Efficacy and Safety Trial of House Dust Mite Sublingual Immunotherapy Tablet, MK-8237, Using an Environmental Exposure Chamber (2014) (3)
Allergen-specific immunotherapy. (2014) (3)
SQ house dust mite sublingual immunotherapy tablet subgroup efficacy and local application site reaction duration. (2018) (3)
87 – Injection Immunotherapy for Inhalant Allergens (2014) (3)
Use of Modified Radioallergosorbent Testing in Determining Initial Immunotherapy Doses (1985) (3)
Sublingual Immunotherapy for Aeroallergens: Optimal Patient Dosing, Regimen and Duration (2014) (2)
The beneficial effect of dog exposure is modified by genetic phenotype (2004) (2)
Langerhans cell–like dendritic cells and inflammatory dendritic epidermal cell–like dendritic cells induce distinct T-cell responses (2004) (2)
Lack of Effect of Promoter, Coding and 3′ Polymorphisms of the β2-adrenergic Receptor (ADRB2) on the Clinical Response to Salmeterol Alone or with Fluticasone Propionate in Subjects with Asthma (2008) (2)
Exhaled nitric oxide: Does it add anything to asthma management? (2003) (2)
496 The role of Chlamydia pneumoniae in reversible obstructive airway disease (1996) (2)
New developments in bronchodilator therapy. (1996) (2)
ONSET OF BRONCHODILATION WITH BUDESONIDE AND FORMOTEROL ADMINISTERED IN ONE PRESSURIZED METERED-DOSE INHALER IN PATIENTS WITH MODERATE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2008) (2)
The importance of allergens in the development of asthma and the persistence of symptoms. (2000) (2)
CARDIOVASCULAR SAFETY OF NEBULIZED FORMOTEROL IN COPD PATIENTS: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (2007) (2)
Immunotherapy coming of age: notable advances during the first hundred years (2017) (2)
Asthma Diagnosis and Differential Diagnosis (2003) (2)
Allergens in commercial house dust. (1982) (2)
Pain perception and performance of three devices for single-site allergen skin testing. (2014) (2)
Iconographies supplémentaires de l'article : Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome (2013) (2)
Dermographia caused by IgE mediated hypersensitivity to penicillin (1982) (2)
How important is proper dosing for subcutaneous and sublingual allergy immunotherapy? (2021) (2)
Diagnostic procedures in allergy II. Bronchial provocation testing. (1983) (2)
Mechanisms of asthma and allergic inflammation AAAAI / ACAAI Task force report * Sublingual immunotherapy : A comprehensive review (2)
Meeting the obligation to balance bioethics and clinical trial design in asthma. (2010) (2)
Food and Drug Administration reclassification of allergens for diagnosis and treatment: now is the time to be heard. (2012) (2)
Case report: an unusual reaction to foods? (1992) (1)
Preparing Subcutaneous Allergen Vaccines (2014) (1)
Future advances of immunotherapy. (2001) (1)
Pollen-associated lipid mediators: When pollen meets eosinophil (2004) (1)
Curcumin does not significantly affect immediate skin tests. (2022) (1)
299 Double-blind study of long-term oral terbutaline: Efficacy and side effects (1985) (1)
SMART AND ASTHMA-RELATED MORTALITY: EXTRAPOLATIONS BASED UPON U.S. ASTHMA DEATH RATE (2006) (1)
Efficacy and safety of standardized short ragweed sublingual immunotherapy tablet (SLIT-T) treatment in Canadian subjects with ragweed pollen-induced rhinitis with or without conjunctivitis (2014) (1)
The clinical relevance of IgE. (1982) (1)
Design and implementation of a patient education center for the childhood asthma management program (1998) (1)
Efficacy and safety of SQ-standardised grass allergy immunotherapy tablet in European and North American adults (2011) (1)
THE NATIONAL ASTHMA EDUCATION AND PREVENTION PROGRAM 2007 REVISION OF THE ASTHMA TREATMENT GUIDELINES (2008) (1)
Issues in allergen extract mixes. (1993) (1)
Dynamics of isoproterenol subsensitivity in guinea pig airway smooth muscle (1981) (1)
Effector and regulatory T cells in fixed drug eruption (2003) (1)
Standardized allergen extracts for allergen immunotherapy. (2022) (1)
How our treatment of asthma has changed over the last half century. (2021) (1)
Impact of Solicitation of Adverse Events on the Safety Profile of 12 SQ House Dust Mite Sublingual Immunotherapy Tablet (2017) (1)
Budesonide and Formoterol in One Metered-Dose Inhaler Improves Health-Related Quality of Life in Adults with Mild to Moderate Persistent Asthma Previously Treated with Inhaled Corticosteroids (2007) (1)
602 Evaluation of cytokines in nasal secretions after nasal antigen challenge (2000) (1)
ANTIGENS AND ALLERGENS (1991) (1)
The return of the mixed respiratory bacterial vaccine. (2022) (1)
Efficacy of 12 SQ House Dust Mite Sublingual Immunotherapy Tablet in Monosensitized and Polysensitized Subjects (2017) (1)
Double-blind study of suppression of indoor fungi and bacteria by the PuriDyne biogenic air purifier. (1991) (1)
The Pharmacotherapy of Rhinitis, Conjunctivitis and Asthma (2014) (1)
474 Local nasal immunotherapy (LNIT) with aqueous weed extract is an effective therapy for weed induced rhinitis (1996) (1)
Indications for and preparing and administering subcutaneous allergen vaccines (2020) (1)
One airway disease—chronic rhinosinusitis and asthma (2003) (1)
Skin testing in allergy diagnosis (2006) (1)
More support for the one-airways concept (2004) (1)
Safety of long-acting β-agonists. Commentary and Authors' reply (2006) (1)
Unresponsive wheezing to asthma therapy in a 32-year-old female. (2003) (1)
Incidence of asthma exacerbations by season and the effects of treatment with fluticasone propionate/salmeterol (FSC) or fluticasone propionate (FP) compared with montelukast (2005) (1)
P450 EFFICACY AND SAFETY OF RAGWEED SLIT-TABLET FROM A LARGE TRIAL IN CHILDREN WITH ALLERGIC (2019) (1)
Stepwise therapy of bronchial asthma: the role of beta-adrenergic agonists. (1985) (1)
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL EVALUATING THE SAFETY AND EFFICACY OF ETANERCEPT 25 TWICE WEEKLY IN PATIENTS WITH SEVERE PERSISTENT ASTHMA (2007) (1)
IgG subclasses in asthmatic patients. (1983) (1)
Safety of Year-Round Initiation with SQ House Dust Mite Sublingual Immunotherapy Tablet (2017) (1)
Corticosteroids and theophylline clearance. (1987) (1)
Assessing asthma control: Beyond the FEV1 (2004) (1)
Cephalosporin use in penicillin-allergic patients (2004) (1)
Evaluation of SQ-House Dust Mite Sublingual Immunotherapy Tablet One-Year after Completion of a 24-Week Treatment Period (2016) (1)
Corticosteroid dosing and asthma control. (2001) (1)
Drug hypersensitivity: Beyond the hapten concept (2004) (1)
To mix or not to mix in allergy immunotherapy vaccines (2021) (1)
Underprescribing of inhaled corticosteroids continues (2003) (1)
Efficacy of House Dust Mite Sublingual Immunotherapy‐Tablet in Tree and/or Grass Poly‐Sensitized Subjects: 605 (2019) (1)
Esophagitis from pollens (2003) (0)
The immune response in human beings to Amb a 1 linked to ISS DNA (2004) (0)
Concentrations for skin testing with antibiotics (2003) (0)
Genes, farmers, and asthma (2004) (0)
An Update on the Efficacy and Safety of Subcutaneous (SCIT) and Sublingual (SLIT) Immunotherapy (2019) (0)
SLIT and SCIT: What Should We Use? (2016) (0)
Allergen Sensitivity Profile of Subjects with Allergic Rhinitis with/without Conjunctivitis Participating in Clinical Trials of Timothy Grass and Short Ragweed Sublingual Immunotherapy Tablets (2015) (0)
495 The effects of salmeterol on the response of albuterol: An analysis by Beta2-adrenergic receptor polymorphisms (2000) (0)
A 33-year-old Caucasian woman with asthma and emphysema. (1992) (0)
Timothy Grass Allergy Immunotherapy Tablets Reduce Nasal and Ocular Symptoms Associated With Allergic Rhinoconjunctivitis During Grass Pollen Season in North American Children and Adults: 2 Randomized, Placebo-Controlled Trials (2012) (0)
2. PEAK EXPIRATORY FLOW MONITORING IN THE MANAGEMENT OF BRONCHIAL ASTHMA. (1992) (0)
Effects Of MN-001 In Patients With Mild-to-moderate Asthma In A Randomized, Double-blind And Placebo-controlled Phase II Study (2007) (0)
Magnitude of changes in patient symptom and medication scores in grass allergy immunotherapy trials: dependency on levels of pollen exposure (2014) (0)
Effect of Allergy Immunotherapy Tablet in Patients with or without Local Application-Site Reactions (2013) (0)
TGF-β in human milk is associated with wheeze in infancy (2003) (0)
Sputum mediator levels resistant to inhaled corticosteroids in chronic cough (2004) (0)
Effect of the Inhaled Corticosteroid Mometasone Furoate on Small Airway Patency in Patients with Asthma (2009) (0)
The selection of atopic allergens. (1981) (0)
Fish oil intervention to prevent infant allergy (2003) (0)
Hydrofluoroalkane-134a beclomethasone or chlorofluorocarbon fluticasone: Effect on small airways in poorly controlled asthma* (2003) (0)
Impact of Ragweed SLIT-Tablets on Asthma Outcomes in a Large Trial of Children with Allergic Rhinoconjunctivitis (2020) (0)
683 The effect of prednisone and methyl prednisolone in allergic asthma (1991) (0)
SCIT and SLIT: Optimal Dosing, Regimen and Duration (2014) (0)
COX-2 contribution to eosinophilic inflammation in asthma (2003) (0)
Mediator measurements during an artificial allergy season: Increased IL-5 and eosinophilic cationic protein (ECP) but no evidence of priming (2004) (0)
Levosalbutamol: a viewpoint by Harold S. Nelson. (1999) (0)
In My Opinion - Interview with the Expert (2000) (0)
P066 Evidence for the beneficial effects of SQ house dust mite sublingual immunotherapy tablets on asthma (2016) (0)
Asthma variability over time (2003) (0)
Efficacy of the SQ HDM SLIT-tablet on House Dust Mite Induced Allergic Conjunctivitis (2018) (0)
New onset dyspnea with reversible airway obstruction in a 70-year-old man. (1995) (0)
Open Wide: Multiple Allergen SLIT and OIT (2017) (0)
Epicutaneous superantigen sensitization induces allergic skin inflammation (2003) (0)
Primary ciliary dyskinesia: Observe the beat pattern! (2003) (0)
Allergy immunotherapy: Literature Review 2022. (2023) (0)
Subcutaneous immunotherapy (2006) (0)
CorrespondenceComments on the Salmeterol Multicenter Asthma Research Trial (2006) (0)
P438 Efficacy of SQ SLIT-tablets in mono- and poly-sensitized HDM, grass, and ragweed allergic subjects (2017) (0)
A possible new role for blocking antibody (2003) (0)
Stress and atopy: The mind-body connection (2004) (0)
The natural history of asthma. (1991) (0)
The Editors[apos ] Choice (2001) (0)
IgE branching out to dendritic cells (2003) (0)
REVIEW ARTICLE Long-Acting Inhaled Beta Agonists (1995) (0)
Editors' choiceThe Editors' Choice (2006) (0)
B2AR association analysis in CAMP (2003) (0)
A novel natriuretic peptide combines bronchodilator and anti-inflammatory activity (2004) (0)
Frankly, Scarlett, I do give ADAM (2003) (0)
Subsensitivity to the bronchodilator action of beta 2-adrenergic agonists. (1995) (0)
Delay in onset of immunomodulating effects of ISS in allergic rhinitis (2004) (0)
Iconographies supplémentaires de l'article : Are meta-analysis–based comparisons solid evidence? (2013) (0)
Outpatient Management of Asthma (1998) (0)
Lower Respiratory-Related Events in Adults and Children With Allergic Rhinoconjunctivitis Receiving Timothy Grass Allergy Immunotherapy Tablet (2011) (0)
CorrespondenceWhy SMART About Second-Line Treatment When First-Line Treatment Is Being Ignored? (2006) (0)
Duration and Recurrence of Local Site Reactions Associated with 12 SQ House Dust Mite Sublingual Immunotherapy Tablet Treatment (2017) (0)
Treatment Effect of House Dust Mite Sublingual Immunotherapy Tablet for Allergic Rhinitis with/without Conjunctivitis (2015) (0)
461 Effect of beclomethasone and theophylline on nonspecific bronchial hyperresponsiveness (BHR) in asthmatics exposed and not exposed to allergens to which they are sensitive (1991) (0)
The Pharmacotherapy of Rhinitis and Asthma (2021) (0)
The Editors[rsquo ] Choice (2000) (0)
Evaluation of a Young Woman Presenting for Treatment of Asthma (2002) (0)
Efficacy and safety of MK-7243: a grass allergy sublingual immunotherapy tablet evaluated in Canadian adults and children (2014) (0)
Extrapolating Evidence Based Medicine of AIT into Clinical Practice in the US. (2022) (0)
Molecular mechanisms in allergy and clinical immunology Molecular pathology of allergic airway disease. II: Upper airway disease (2000) (0)
COMPARISON OF SINGLE-DOSE EFFICACY OF ALBUTEROL-HYDROFLUOROALKANE BREATH-ACTUATED INHALER AND ALBUTEROL-HYDROFLUOROALKANE METERED-DOSE INHALER IN ASTHMA PATIENTS WITH POOR INHALER COORDINATING ABILITY (2008) (0)
Allergen Immunotherapy (2021) (0)
Lability of blocking antibody during ragweed pollen immunotherapy (RWI) (1982) (0)
Induction of nitric oxide by mite allergens and whole fecal pellets (2003) (0)
Dry powder inhalers for asthma might contain traces of milk proteins (2004) (0)
147. The effect of preservatives and dilution on the potency of Russian thistle extract (1978) (0)
Is sublingual immunotherapy better than subcutaneous immunotherapy (2006) (0)
P451 SUPER- AND NON/LOW-RESPONDERS AMONG SUBJECTS WITH ALLERGIC RHINOCONJUNCTIVITIS RECEIVING HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET (2019) (0)
Immunologic and atopic aspects of pregnancy and lactation. (1986) (0)
Clarification of salmeterol studies. (2003) (0)
Novel GM-CSF gene polymorphisms and atopic dermatitis (2003) (0)
Chapter 123. Recalcitrant Asthma (2008) (0)
Triamcinolone acetonide delivery via a jet nebulizer (1993) (0)
ADVERSE EVENT PROFILE OF SQ HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET AFTER TREATMENT INTERRUPTION (2018) (0)
Pet ownership and sensitization (2003) (0)
Research abstracts presented at the Western Society of Allergy, Asthma, and Immunology Meeting, January 24‐28, 2010 (2010) (0)
Paradoxical Bronchospasm With a Near-Fatal Reaction to Albuterol-HFA and Levalbuterol inhalation solution leading to Intubation in an Adult Asthmatic (2007) (0)
Reduced glucocorticoid receptor translocation in steroid-insensitive asthma (2004) (0)
Effect of Timothy Grass Allergy Immunotherapy Tablet on Allergic Rhinoconjunctivitis Eye Symptoms in North American Adults and Children (2011) (0)
Allergy immunotherapy (2022) (0)
Ragweed SLIT-Tablets Induce Similar Patterns of Allergen-Specific IgE and IgG4 Responses in Children and Adults with Allergic Rhinoconjunctivitis (2020) (0)
Commentary 2 (0)
Subsensitivity to the bronchodilator action of β2-adrenergic agonist (1995) (0)
Role of Allergen-Speciﬁc Immunotherapy in Childhood Asthma (2005) (0)
Toxic eosinophil granule proteins persist in skin for weeks (2003) (0)
Neutrophils in severe asthma: Innocent bystanders or active participants? (2003) (0)
Efficacy and Safety of Ragweed SLIT-Tablets Across Peak and Entire Season in Children with Allergic Rhinoconjunctivitis (2020) (0)
A double-blind study of suppression of indoor mold and bacteria by the Puridyne biogenic air purifier (BAP). (1990) (0)
Daclizumab Improves Asthma Control in Patients with Moderate to Severe Persistent Asthma: A Randomized, Controlled Trial (2009) (0)
IL-9: A key regulator of human bronchial hyperresponsiveness—the holy grail in asthma? (2004) (0)
Double-blind placebo-controlled dose-response study of immunotherapy with standardized cat extract (2002) (0)
Risk Factors for Allergies and Asthma (2021) (0)
Efficacy of Timothy Grass Allergy Immunotherapy Tablet During Peak Grass Pollen Season in North American Adults (2011) (0)
History of specific immunotherapy. (2013) (0)
Safety of long-acting beta-agonists. (2006) (0)
Sorting out the messages from β2-adrenergic receptor polymorphisms (2003) (0)
CHAPTER 23 – In Vivo Testing for Immunoglobulin E-Mediated Sensitivity (2010) (0)
Difficult asthma in children (2004) (0)
The Response To Sublingual Immunotherapy With Grass Pollen Extract Administered As A Single Extract Or As Part Of A Multi-Allergen Extract In Patients With Seasonal Allergic Rhinitis Caused By Grass Pollen (2009) (0)
Costs in the Senior Seminaries of The Church of Jesus Christ of Latter-Day Saints (1935) (0)
Utility of FeNO in the Diagnosis and Management of Asthma: Comparison to Other Measures (2014) (0)
Consistent Efficacy and Safety of 12 SQ House Dust Mite Sublingual Immunotherapy Tablet Among Subgroups with Allergic Rhinoconjunctivitis (2017) (0)
Contents, Vol. 55, 1977 (1977) (0)
Why Immunotherapy in the USA is Different than Immunotherapy in Europe (2018) (0)
A 47-year-old woman with progressive dyspnea and cough. (2002) (0)
Assessment of the efficacy and development of alpha adrenergic (alpha-Ad) subsensitivity with oral pseudoephedrine (PsE) (1982) (0)
Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC) (2011) (0)
Primary ciliary dyskinesia (2003) (0)
The World Trade Center collapse: Consequences for asthmatic children (2004) (0)
Interaction of genes and environment in Japanese cedar pollinosis (2003) (0)
ROLE OF SYSTEMIC AND INHALED GLUCOCORTICOIDS IN ASTHMA (1999) (0)
470 Double blind, placebo-controlled study of the treatment of asthma with pyridoxine (1991) (0)
Lack of pretreatment cost-effectiveness and side effects of omalizumab versus prednisone/montelukast on tolerability of immunotherapy Reply (2011) (0)
What will allergen immunotherapy look like in the future? (2012) (0)
New insights into the role of infection in asthma (2003) (0)
1-ii) THE ROLE OF THE ENVIRONMENT IN THE INCREASING PREVALENCE OF BRONCHIAL ASTHMA. (1992) (0)
CorrespondenceCause of Death in the SMART Trial (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Harold S. Nelson?

Harold S. Nelson is affiliated with the following schools:

Tampere University

Harold S. Nelson's Academic­Influence.com Rankings

Harold S. Nelson's Degrees

Why Is Harold S. Nelson Influential?

Harold S. Nelson's Published Works

Published Works

What Schools Are Affiliated With Harold S. Nelson?

Harold S. Nelson's AcademicInfluence.com Rankings